Page last updated: 2024-10-15

carthamine

Description

carthamine: composed of two chalcones; from Carthamus tinctorius; the conjugated bonds cause a red color; derived from precarthamin by a decarboxylase; do not confuse with carthamidin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
CarthamusgenusA plant genus of the family ASTERACEAE.[MeSH]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]

Cross-References

ID SourceID
PubMed CID135565560
CHEBI ID80810
SCHEMBL ID121899
MeSH IDM0269776

Synonyms (30)

Synonym
c.i. natural red 26
einecs 252-981-1
natural red 26
unii-p9zt730wws
carthamus
4-cyclohexene-1,3-dione, 6-beta-d-glucopyranosyl-2-((3-beta-d-glucopyranosyl-2,3,4-trihydroxy-5-(3-(4-hydroxyphenyl)-1-oxo-2-propenyl)-6-oxo-1,4-cyclohexadien-1-yl)methylene)-5,6-dihydroxy-4-(3-(4-hydroxyphenyl)-1-oxo-2-propenyl)-
carthamus red ap
liofresh red cr
p9zt730wws ,
carthamin
carthamine
36338-96-2
C16941
S5110
SCHEMBL121899
liofresh red cr-7000
carthamus red
natural red 26 [inci]
carthamin [mi]
4-cyclohexene-1,3-dione, 6-.beta.-d-glucopyranosyl-2-((3-.beta.-d-glucopyranosyl-2,3,4-trihydroxy-5-(3-(4-hydroxyphenyl)-1-oxo-2-propenyl)-6-oxo-1,4-cyclohexadien-1-yl)methylene)-5,6-dihydroxy-4-(3-(4-hydroxyphenyl)-1-oxo-2-propenyl)-, (s-(r*,r*))-
CHEBI:80810
AKOS030526139
DTXSID50897503
HY-N6646
Q419193
(s,z)-5,6-dihydroxy-4-((e)-3-(4-hydroxyphenyl)acryloyl)-2-(((s)-2,3,4-trihydroxy-5-((e)-3-(4-hydroxyphenyl)acryloyl)-6-oxo-3-((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)cyclohexa-1,4-dien-1-yl)methylene)-6-((2r,3r,4s,5s,6r
AS-18743
HMS3886K13
CCG-270568
CS-0063546

Bioavailability

ExcerptReference
" Information on the bioavailability of complex mixtures of xenobiotics and degradation products cannot be totally provided by chemical analytical data, but results from bioassays can integrate the effects of pollutants in complex mixtures."( Ecotoxicological evaluation of diesel-contaminated soil before and after a bioremediation process.
Albores, A; Guerrero, M; Molina-Barahona, L; Ramírez, S; Romero, I; Vega-Jarquín, C; Vega-Loyo, L, 2005
)
"The oral bioavailability of carthamin was 41."( [Screening and identification of potential targets of carthamin against sepsis].
Chen, G; Guo, S; Xu, Y, 2021
)

Dosage Studied

ExcerptReference
"0 mg/mL), shifting the inhibitory dose-response curves to the left."( Cholinomimetic and calcium channel blocking activities of Carthamus oxycantha.
Ahmad, VU; Bukhari, IA; Gilani, AH; Khan, AU; Khan, RA; Ullah, F, 2005
)
" These elements in their appropriate dosage range are considered to be beneficial to health."( Analysis of trace elements in Chinese therapeutic foods and herbs.
Xu, H; Xu, HE, 2009
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hydroxycinnamic acidAny member of the class of cinnamic acids carrying one or more hydroxy substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (83)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.20)18.7374
1990's0 (0.00)18.2507
2000's26 (31.33)29.6817
2010's43 (51.81)24.3611
2020's13 (15.66)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (3.30%)5.53%
Reviews1 (1.10%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other87 (95.60%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]